Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06924021 · ClinicalTrials.gov registry record
Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)
A clinical trial of Age-related Macular Degeneration, sponsored by University of Wisconsin, Madison.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 14
- Study locations
NCT06924021 is a study of Age-related Macular Degeneration that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 1,000 participants, below the 1,494-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (33% lower). The trial reports 14 study locations across 7 states.
The verdict
NCT06924021, a study of Age-related Macular Degeneration, is actively recruiting participants, sponsored by University of Wisconsin, Madison.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 14
- Study locations
Study Summary
1000 participants from up to 25 international locations who are at least 50 years old with either healthy eyes or a diagnosis of Age-Related Macular Degeneration (AMD) will be consented to provide images of their eyes for a new dataset. This dataset is an important step in developing an Artificial Intelligence (AI) based screening tool for AMD.
Conditions Studied
Interventions
- OTHER Retinal Imaging
Study Locations (14)
Other
- Charles Research Center - Buenos Aires
- Adelaide Eye and Retina Centre - Adelaide
- Centre Hospialier Intercommunal de Paradis (Centre Monticelli Paradis) - Marseille
- University of Bonn - Department of Ophthalmology - Bonn
- Aga Khan University - Karachi
Texas
- Retina Foundation of the Southwest - Dallas
- Valley Retina Institute - McAllen
- Retina Consultants of Texas (Houston) - The Woodlands
Tamil Nadu
- Sankara Nethralaya, Medical Research Foundation - Chennai
- Aravind Eye Hospital - Chennai
North Dakota
- Bergstrom Eye Research LLC - Fargo
Pennsylvania
- Erie Retina Research - Erie
Utah
- University of Utah - John A. Moran Eye Center - Salt Lake City
Wisconsin
- University Station Eye Care Clinic - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2025-05-12 |
| Est. Completion | 2026-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06924021
The ClinicalTrials.gov registry entry for NCT06924021 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,494-participant average among 74 other Age-related Macular Degeneration trials with a reported enrollment target (33% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Age-related Macular Degeneration appearing as the primary indexed condition, and to 1 intervention - of which Retinal Imaging is the first listed.
NCT06924021 reports 14 study locations spanning 7 distinct geographic areas - top geographies include Other, Texas, Tamil Nadu.
Frequently Asked Questions
What is clinical trial NCT06924021 about?
NCT06924021 is a clinical study titled "Age-Related Macular Degeneration Benchmark Imaging Dataset (ABID)". 1000 participants from up to 25 international locations who are at least 50 years old with either healthy eyes or a diagnosis of Age-Related Macular Degeneration (AMD) will be consented to provide images of their eyes for a new dataset. This dataset is an important step in developing an Artificial I...
What is the current status of trial NCT06924021?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2025-05-12. Estimated completion is 2026-11.
What conditions does trial NCT06924021 study?
This clinical trial studies the following conditions: Age-related Macular Degeneration.
What interventions are being tested in trial NCT06924021?
The interventions under investigation include: Retinal Imaging (OTHER).
Who is sponsoring clinical trial NCT06924021?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06924021 being conducted?
This trial has 14 study locations across North Dakota, Pennsylvania, Texas, Utah, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Macular Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
RECRUITING · Phase 2
-
Village-Integrated Eye Worker Trial II
RECRUITING · NA
-
High Resolution Retinal Imaging
RECRUITING
-
Visual Remapping to Aid Reading With Field Loss
RECRUITING · NA
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RECRUITING · Phase 1
-
Effects of Goji vs. Fiber on Macular Degeneration
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.